Capital International Sarl Karuna Therapeutics, Inc. Transaction History

Capital International Sarl

  • $3.71 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024
BUY
$161.01 - $317.85 $1.57 Million - $3.1 Million
9,759 Added 98.93%
19,624 $6.21 Million
Q3 2023

Nov 13, 2023
BUY
$164.66 - $218.08 $103,241 - $136,736
627 Added 6.79%
9,865 $1.67 Million
Q2 2023

Aug 11, 2023
BUY
$176.32 - $240.22 $1.63 Million - $2.22 Million
9,238 New
9,238 $2 Million

Others Institutions Holding KRTX

# of Institutions
10
Shares Held
332K
Call Options Held
0
Put Options Held
0
View Full List

About Karuna Therapeutics, Inc.

KRTX Quotes by TradingView
  • Ticker KRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,965,000
  • Description
  • Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...
More about KRTX
Track This Portfolio

Track Capital International Sarl Portfolio

Follow Capital International Sarl and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International Sarl, based on Form 13F filings with the SEC.

News

Stay updated on Capital International Sarl with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email